| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413209A1 Modulation of a.beta. levels by .beta.-secretase bace2 |
| 01/03/2002 | CA2412701A1 Methods for producing modified glycoproteins |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |
| 01/03/2002 | CA2412211A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2412084A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/03/2002 | CA2381241A1 Truncated egf receptor |
| 01/02/2002 | EP1167537A1 Process for producing monoclonal antibody |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167385A2 Human follicle stimulating hormone receptor |
| 01/02/2002 | EP1167384A1 HVEGF Receptor as Vascular endothelial cell growth factor antagonists |
| 01/02/2002 | EP1166112A1 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
| 01/02/2002 | EP1165836A2 Schizophrenia associated genes, proteins and biallelic markers |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165826A1 Method for synthesis of polypeptides in cell-free systems |
| 01/02/2002 | EP1165812A2 Protozoan expression system |
| 01/02/2002 | EP1165809A2 Leukotriene b4 receptor transgenic mammals |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165798A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/02/2002 | EP1165796A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165787A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/02/2002 | EP1165785A1 48 human secreted proteins |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165782A1 Improved methods for recombinant peptide production |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165780A2 Flint polypeptide analogs |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165777A2 Genes encoding human potassium channel proteins |
| 01/02/2002 | EP1165775A2 Recombination of insertion modified nucleic acids |
| 01/02/2002 | EP1165774A2 Casb619 involved in colon cancers |
| 01/02/2002 | EP1165758A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 01/02/2002 | EP1165757A1 Encryption of traits using split gene sequences |
| 01/02/2002 | EP1165750A1 Diagnosis of whipple disease |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | EP1165615A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165603A1 Human neurogenin 3-encoding nucleotide sequences |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165597A1 Bifunctional molecules for delivery of therapeutics |
| 01/02/2002 | EP1165592A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
| 01/02/2002 | EP1165591A1 47 human secreted proteins |
| 01/02/2002 | EP1165590A1 49 human secreted proteins |
| 01/02/2002 | EP1165587A1 50 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165185A2 Human tumor necrosis factor receptor-like 2 |
| 01/02/2002 | EP1165133A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 01/02/2002 | EP1165124A1 Recombinant neospora antigens and their uses |
| 01/02/2002 | EP1165114A1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 01/02/2002 | EP1164838A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP0877549A4 Methods and compositions for the reduction of xenotransplantation rejection |
| 01/02/2002 | EP0833843B1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/02/2002 | EP0822829B1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 01/02/2002 | CN1329667A Fungal transcriptional activator useful in methods for producing polyptides |
| 01/02/2002 | CN1329508A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/02/2002 | CN1329500A Anti-dandruff composition comprising antifungal polypeptide |
| 01/01/2002 | US6335435 Nucleotide sequences coding enzymatic polypeptides; for use in treatment of genetic disorders |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335428 Monoclonal antibodies; for use as drug screening tool |
| 01/01/2002 | US6335424 ribG |
| 01/01/2002 | US6335318 Antimicrobial theta defensins and methods of using same |
| 01/01/2002 | US6335196 13C,15N ,2H labeled proteins for NMR structure determinations and their preparation |
| 01/01/2002 | US6335194 Antisense modulation of survivin expression |
| 01/01/2002 | US6335183 Stress proteins and uses therefor |
| 01/01/2002 | US6335182 Recombinant Haemophilus influenzae adhesin proteins |
| 01/01/2002 | US6335181 Generating polypeptide; for use in the diagnosis, prevention and treatment of bacterial infection |
| 01/01/2002 | US6335180 Nucleic acid sequences encoding capsaicin receptor and uses thereof |
| 01/01/2002 | US6335179 Directed evolution of thermophilic enzymes |
| 01/01/2002 | US6335175 Anti-human pre-B cell receptor antibody |
| 01/01/2002 | US6335163 Aggolomeration of receptor proteins; for use in diagnosis, treatment, and prevention of tumors, parasitic, bacterial and viral infections; for use in gene therapy |
| 01/01/2002 | US6335160 Methods and compositions for polypeptide engineering |
| 01/01/2002 | US6335158 Immunologically active peptide of given amino acid sequence which binds antibodies against retroviruses of the hiv type; diagnostic kits |
| 01/01/2002 | US6335014 Medicament for suppressing cancer metastasis |
| 01/01/2002 | CA2020817C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 01/01/2002 | CA1341331C Viral vector and recombinant dna coding for one or more structural protein (ha, f and/or np) of a morbillivirus, infected cell culture, resulting proteins, vaccine and antibodies |
| 12/27/2001 | WO2001098515A2 Gene-regulating conjugates |
| 12/27/2001 | WO2001098509A2 Grain processing method and transgenic plants useful therein |
| 12/27/2001 | WO2001098506A2 Methods and means for regulation of gene expression |
| 12/27/2001 | WO2001098499A1 Antigenic polypeptides |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098494A1 Ligand to gpr8 and dna thereof |
| 12/27/2001 | WO2001098493A1 Insulin-like growth factor-binding protein |
| 12/27/2001 | WO2001098491A2 Osteolevin gene polymorphisms |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098489A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |
| 12/27/2001 | WO2001098486A1 Mutation associated with epilepsy |
| 12/27/2001 | WO2001098483A1 Gene encoding novel protocadherin-like protein |
| 12/27/2001 | WO2001098481A2 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | WO2001098471A2 Human phosphodiesterases |
| 12/27/2001 | WO2001098470A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 12/27/2001 | WO2001098468A2 Proteases |
| 12/27/2001 | WO2001098455A2 Method for preparing a physiologically active il-18 polypeptide |
| 12/27/2001 | WO2001098453A2 Modified construct downstream of the initiation codon for recombinant protein overexpression |